CYP3A7
Cytochrome P450 3A7
Also known as: CP37, CP3A7_HUMAN, P450-HFLA
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P24462
- Gene
- CYP3A7
- Ensembl
- ENSG00000160870
- Chromosome
- 7
- Canonical length
- 503 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted membrane proteins
- Subcellular location
- Vesicles,Cytosol
OverviewNCBI Gene
This gene encodes a member of the cytochrome P450 superfamily of enzymes, which participate in drug metabolism and the synthesis of cholesterol, steroids and other lipids. This enzyme hydroxylates testosterone and dehydroepiandrosterone 3-sulphate, which is involved in the formation of estriol during pregnancy. This gene is part of a cluster of related genes on chromosome 7q21.1. Naturally-occurring readthrough transcription occurs between this gene and the downstream CYP3A51P pseudogene and is represented by GeneID:100861540. [provided by RefSeq, Jan 2015]
Canonical amino-acid sequenceUniProt
503 residues, UniProt reviewed canonical sequence.
>P24462|CYP3A7
1 MDLIPNLAVE TWLLLAVSLI LLYLYGTRTH GLFKKLGIPG PTPLPFLGNA LSFRKGYWTF
61 DMECYKKYRK VWGIYDCQQP MLAITDPDMI KTVLVKECYS VFTNRRPFGP VGFMKNAISI
121 AEDEEWKRIR SLLSPTFTSG KLKEMVPIIA QYGDVLVRNL RREAETGKPV TLKHVFGAYS
181 MDVITSTSFG VSIDSLNNPQ DPFVENTKKL LRFNPLDPFV LSIKVFPFLT PILEALNITV
241 FPRKVISFLT KSVKQIKEGR LKETQKHRVD FLQLMIDSQN SKDSETHKAL SDLELMAQSI
301 IFIFAGYETT SSVLSFIIYE LATHPDVQQK VQKEIDTVLP NKAPPTYDTV LQLEYLDMVV
361 NETLRLFPVA MRLERVCKKD VEINGMFIPK GVVVMIPSYV LHHDPKYWTE PEKFLPERFS
421 KKNKDNIDPY IYTPFGSGPR NCIGMRFALV NMKLALVRVL QNFSFKPCKE TQIPLKLRFG
481 GLLLTEKPIV LKAESRDETV SGALocalizationUniProt · AlphaFold · HPA
Whether an antibody against CYP3A7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 285 nTPM
Expression across tissuesHPA
Tissue
- liver: 285 nTPM
- kidney: 7.9 nTPM
- gallbladder: 6.1 nTPM
- breast: 2.5 nTPM
- lung: 2.3 nTPM
- small intestine: 1.7 nTPM
Single-cell type
- cholangiocytes: 5.9 nCPM
- hepatocytes: 0.9 nCPM
- basal prostatic cells: 0.6 nCPM
- cardiomyocytes: 0.3 nCPM
- prostatic club cells: 0.1 nCPM
- adipocytes: 0 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 0.5 nTPM
- medulla oblongata: 0.4 nTPM
- hypothalamus: 0.3 nTPM
- basal ganglia: 0.2 nTPM
- cerebellum: 0.2 nTPM
- hippocampal formation: 0.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.27
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.27
- DepMap mean gene effect
- 0.11
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- estrogen metabolic process
- lipid hydroxylation
- oxidative demethylation
- retinoic acid metabolic process
- retinol metabolic process
- steroid biosynthetic process
- steroid metabolic process
- xenobiotic metabolic process
Molecular functions
- all-trans retinoic acid 18-hydroxylase activity
- estrogen 16-alpha-hydroxylase activity
- estrogen 2-hydroxylase activity
- heme binding
- iron ion binding
- monooxygenase activity
- oxygen binding
- retinoic acid 4-hydroxylase activity
- steroid hydroxylase activity
- testosterone 6-beta-hydroxylase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CYP3A7 as an antibody target. Whether an autoantibody or antibody against CYP3A7 could matter depends on whether native CYP3A7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CYP3A7 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CYP3A7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...